We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Research reveals HR-19011 improves outcomes in hematologic malignancies by activating the HRI–eIF2α–ATF4 pathway, suggesting new therapeutic avenues.
Sequences of siRNAs used for gene silencing
No takes yet. Share an insight, caveat, or question.
Kim et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: